Overcoming roadblocks in the development of vaccines for leishmaniasis

PM Kaye, S Mohan, C Mantel, M Malhame… - Expert Review of …, 2021 - Taylor & Francis
Introduction The leishmaniases represent a group of parasitic diseases caused by infection
with one of several species of Leishmania parasites. Disease presentation varies because …

Leishmaniasis: Omics approaches to understand its biology from molecule to cell level

I Kumari, D Lakhanpal, S Swargam… - Current Protein and …, 2023 - ingentaconnect.com
Leishmaniasis is the second deadliest vector-borne, neglected tropical zoonotic disease
and is found in a variety of clinical forms based on genetic background. Its endemic type is …

Parasite genotype is a major predictor of mortality from visceral leishmaniasis

CA Grace, KS Sousa Carvalho, MI Sousa Lima… - MBio, 2022 - Am Soc Microbiol
Visceral leishmaniasis (VL) is a potentially fatal disease caused mainly by Leishmania
infantum in South America and Leishmania donovani in Asia and Africa. Disease outcomes …

Identification of Leishmania infantum Epidemiology, Drug Resistance and Pathogenicity Biomarkers with Nanopore Sequencing

J Martí-Carreras, M Carrasco, M Gómez-Ponce… - Microorganisms, 2022 - mdpi.com
The emergence of drug-resistant strains of the parasite Leishmania infantum infecting dogs
and humans represents an increasing threat. L. infantum genomes are complex and …

[HTML][HTML] Geographic origin and vertical transmission of Leishmania infantum parasites in hunting hounds, United States

SU Franssen, MJ Sanders, M Berriman… - Emerging infectious …, 2022 - ncbi.nlm.nih.gov
Vertical transmission of leishmaniasis is common but is difficult to study against the
background of pervasive vector transmission. We present genomic data from dogs in the …

Diversity and within-host evolution of Leishmania donovani from visceral leishmaniasis patients with and without HIV coinfection in northern Ethiopia

SU Franssen, Y Takele, E Adem, MJ Sanders, I Müller… - MBio, 2021 - Am Soc Microbiol
Visceral leishmaniasis (VL) is a fatal disease and a growing public health problem in East
Africa, where Ethiopia has one of the highest VL burdens. The largest focus of VL in Ethiopia …

Synthetic Peptides Selected by Immunoinformatics as Potential Tools for the Specific Diagnosis of Canine Visceral Leishmaniasis

G Moreira, R Maia, N Soares, T Ostolin, W Coura-Vital… - Microorganisms, 2024 - mdpi.com
Diagnosing canine visceral leishmaniasis (CVL) in Brazil faces challenges due to the
limitations regarding the sensitivity and specificity of the current diagnostic protocol …

Miltefosine Unresponsiveness in Visceral Leishmaniasis

R Singh, A Verma, S Ghosh, V Kumar… - … and Solutions Against …, 2024 - Springer
Abstract Treatment failure in visceral leishmaniasis (VL; kala-azar) is an increasing problem
worldwide, primarily due to drug resistance. Pentavalent antimonials were the mainstay of …

Evaluation by molecular docking of inhibitors of the enzyme pteridine reductase 1 from leishmania

JL Araújo, RS Bastos, GT Santos, JL Araújo… - Revista Prevenção de …, 2019 - revistas.ufpi.br
Objective: The objective of this work is to perform a bioactive analysis of Leishmania major
Pteridine Reductase 1 inhibitors (LmPTR1) through in silico molecular docking studies …

Multiple targets of balancing selection in Leishmania donovani complex parasites

CA Grace, S Forrester, VC Silva, A Aare, H Kilford… - bioRxiv, 2021 - biorxiv.org
The Leishmania donovani species complex are the causative agents of visceral
leishmaniasis, which cause 20-40,000 fatalities a year. Here, we conduct a screen for …